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Abstract: Prenatal exposure to infectious or inflammatory insults can increase the risk of developing
neuropsychiatric disorder in later life, including schizophrenia, bipolar disorder, and autism. These
brain disorders are also characterized by pre- and postsynaptic deficits. Using a well-established mouse
model of maternal exposure to the viral mimetic polyriboinosinic-polyribocytidilic acid [poly(I:C)], we
examined whether prenatal immune activation might cause synaptic deficits in the hippocampal formation
of pubescent and adult offspring. Based on the widely appreciated role of microglia in synaptic pruning,
we further explored possible associations between synaptic deficits and microglia anomalies in offspring
of poly(I:C)-exposed and control mothers. We found that prenatal immune activation induced an adult
onset of presynaptic hippocampal deficits (as evaluated by synaptophysin and bassoon density). The
early-life insult further caused postsynaptic hippocampal deficits in pubescence (as evaluated by PSD95
and SynGAP density), some of which persisted into adulthood. In contrast, prenatal immune activation
did not change microglia (or astrocyte) density, nor did it alter their activation phenotypes. The prenatal
manipulation did also not cause signs of persistent systemic inflammation. Despite the absence of overt
glial anomalies or systemic inflammation, adult offspring exposed to prenatal immune activation displayed
increased hippocampal IL-1￿ levels. Taken together, our findings demonstrate that age-dependent synaptic
deficits and abnormal pro-inflammatory cytokine expression can occur during postnatal brain maturation
in the absence of microglial anomalies or systemic inflammation.
DOI: 10.1016/j.bbi.2015.09.015
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1.	  Introduction	  Maternal	   infectious	   or	   inflammatory	   insults	   during	   pregnancy	   have	   been	   repeatedly	  implicated	   in	   the	   etiology	   of	   developmental	   neuropsychiatric	   disorders,	   including	  schizophrenia	   (Brown	   and	  Derkits,	   2010;	   Canetta	   et	   al.,	   2014b),	   autism	   (Atladóttir	   et	   al.,	  2010;	   Brown	   et	   al.,	   2014),	   and	   bipolar	   disorder	   (Canetta	   et	   al.,	   2014a;	   Parboosing	   et	   al.,	  2013).	   Preclinical	   support	   for	   these	   epidemiological	   associations	   has	   been	   obtained	   by	  various	   translational	   rodent	   models	   demonstrating	   multiple	   brain	   and	   behavioral	  abnormalities	   following	   prenatal	   exposure	   to	   infection	   and/or	   immune	   activation	  (reviewed	  in	  Boksa,	  2010;	  Harvey	  and	  Boksa,	  2012;	  Meyer,	  2014;	  Meyer	  and	  Feldon,	  2010).	  Increasing	  evidence	  suggests	  that	  cytokine-­‐associated	  inflammatory	  events,	   together	  with	  downstream	   pathophysiological	   effects	   such	   as	   oxidative	   stress	   and	   (temporary)	  macronutrient	  and	  micronutrient	  deficiency,	  are	  critical	  in	  mediating	  the	  adverse	  effects	  of	  maternal	   infection	   on	   the	   fetal	   system	   (reviewed	   in	   Meyer,	   2014;	   Miller	   et	   al.,	   2013).	  Disruption	   of	   normal	   fetal	   development	   (Meyer	   et	   al.,	   2008;	   Vuillermot	   et	   al.,	   2010),	  together	  with	  subsequent	  changes	  in	  brain	  maturation	  (Hadar	  et	  al.,	  2015;	  Piontkewitz	  et	  al.,	  2011;	  Richetto	  et	  al.,	  2014),	  may	  then	  confer	  increased	  risk	  of	  behavioral	  and	  cognitive	  dysfunctions	  in	  later	  life.	  	   In	  recent	  years,	   there	  has	  been	  growing	  interest	   in	  the	  potential	  role	  of	  microglia	   in	  normal	   brain	   development	   and	   maturation,	   especially	   in	   those	   events	   that	   relate	   to	  synaptic	  pruning	  (Bilimoria	  and	  Stevens,	  2015;	  Kreisel	  et	  al.,	  2014;	  Paolicelli	  et	  al.,	  2011;	  Schafer	  et	  al.,	  2012;	  Schafer	  and	  Stevens,	  2013).	  Microglia	  are	  the	  major	  immunocompetent	  cells	   residing	   in	   the	   brain	   parenchyma	   and	   can	   adopt	   different	   morphological	  characteristics	   and	   functions:	   In	   their	   ramified	   state,	   they	   constantly	   survey	   the	   brain	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microenvironment	   to	  detect	  and	  to	  respond	  to	  alterations	   in	  brain	  homeostasis,	  which	   in	  turn	   can	   induce	   the	   transition	   of	   ramified	   into	   phagocytic	   microglia	   (Gomez-­‐Nicola	   and	  Perry,	   2015).	   In	   contrast	   to	   ramified	   microglia	   with	   small	   cell	   bodies	   and	   extensive	  arborization,	   phagocytic	   microglia	   are	   characterized	   by	   enlarged	   cell	   soma	   and	   less	  arborization.	   As	   phagocytes,	   they	   can	   quickly	   remove	   cellular	   debris	   and	   dying	   neurons,	  thereby	  preventing	  possible	  toxic	  damage	  to	  neighboring	  cells.	  	  	   The	   phagocytic	   capacity	   of	   microglia	   is	   particularly	   important	   during	   early	   brain	  development	   and	   subsequent	   maturation,	   where	   they	   can	   contribute	   to	   the	   removal	   of	  excessive	  synapses	   in	  certain	  neuronal	  pathways	  (Bilimoria	  and	  Stevens,	  2015;	  Kreisel	  et	  al.,	   2014;	   Paolicelli	   et	   al.,	   2011;	   Schafer	   et	   al.,	   2012).	   For	   these	   reasons,	   it	   has	   been	  suggested	  that	  abnormal	  microglia	   functions	  during	  critical	  periods	  of	  brain	  development	  and	   maturation	   may	   be	   an	   important	   etiopathological	   mechanism	   linking	  neuroinflammation	  to	  synaptic	  deficits	  (Rao	  et	  al.,	  2012).	  Synaptic	  deficits	  are	  a	  hallmark	  of	  various	   neurodevelopmental	   brain	   disorders,	   including	   schizophrenia	   and	   autism	  (reviewed	   in	  Eastwood,	  2004;	  Ebrahimi-­‐Fakhari	  and	  Sahin,	  2015;	  Harrison,	  2004).	  These	  disorders	   have	   also	   been	   associated	   with	   altered	   microglia	   functions	   and	   associated	  neuroinflammatory	  changes	  (Arion	  et	  al.,	  2007;	  Doorduin	  et	  al.,	  2009;	  Fillman	  et	  al.,	  2013;	  Fung	  et	  al.,	  2014;	  Morgan	  et	  al.,	  2010;	  Tetreault	  et	  al.,	  2012;	  van	  Berckel	  et	  al.,	  2008;	  Volk	  et	  al.,	   2015).	   It	   remains	   elusive,	   however,	   whether	   and	   to	   what	   extent	   such	   microglial	  abnormalities	  may	  be	  responsible	  for	  the	  development	  of	  synaptic	  deficits	  as,	  for	  example,	  seen	  in	  schizophrenia	  or	  autism	  (Catts	  et	  al.,	  2013;	  Onore	  et	  al.,	  2012).	  	   Against	   these	   backgrounds,	   the	   present	   study	   aimed	   at	   exploring	   potential	  associations	   between	   impaired	   synaptic	   development	   and	   microglial	   abnormalities	   in	   a	  model	  of	  prenatal	  immune	  activation	  with	  relevance	  to	  neurodevelopmental	  disorders.	  We	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used	   a	   well-­‐established	   mouse	   model	   of	   maternal	   treatment	   with	   the	   viral	   mimetic	  polyriboinosinic-­‐polyribocytidilic	   acid	   [poly(I:C)],	   which	   is	   known	   to	   capture	   a	   wide	  spectrum	   of	   neuronal	   and	   behavioural	   abnormalities	   relevant	   to	   psychiatric	   disorders,	  especially	   schizophrenia	   and	   autism	   (reviewed	   in	   Meyer,	   2014;	   Reisinger	   et	   al.,	   2015).	  Prenatal	  poly(I:C)	  exposure	  in	  rats	  has	  also	  been	  shown	  to	  cause	  synaptic	  deficits	  (Forrest	  et	   al.,	   2012;	   Oh-­‐Nishi	   et	   al.,	   2010),	   but	   their	   possible	   association	   with	   microglial	  abnormalities	  and	  related	  neuroimmune	  changes	  remain	  unexplored	  thus	  far.	  	  	   Using	   the	   maternal	   poly(I:C)	   administration	   model	   in	   mice,	   we	   assessed	   the	  expression	  of	  synaptic	  proteins,	  microglia	  density	  and	  activation,	  systemic	  and	  peripheral	  inflammation,	   and	   selected	   behavioral	   functions.	   We	   focused	   our	   neuroanatomical	  investigations	  on	  the	  hippocampus	  for	  two	  main	  reasons.	  First,	  it	  is	  one	  of	  the	  brain	  areas	  strongly	  implicated	  in	  the	  neuropathology	  of	  schizophrenia	  and	  other	  brain	  disorders	  with	  neurodevelopmental	   components	   (Harrison,	   2004;	   Tamminga	   et	   al.,	   2010).	   Second,	   the	  hippocampal	   formation	   is	  markedly	   affected	  by	  prenatal	   immune	   challenge	  and	   is	  of	   key	  interest	  to	  current	  research	  in	  this	  field	  (reviewed	  in:	  Meyer	  and	  Feldon,	  2009;	  Piontkevitz	  et	   al.,	   2012a).	   The	   assessment	   of	   synaptic	   proteins	   included	   synaptophysin,	   bassoon,	  synaptic	   Ras	   GTPase-­‐activating	   protein	   1	   (SynGAP),	   and	   postsynaptic	   density	   protein	   95	  (PSD95).	  Synaptophysin	  and	  bassoon	  are	  two	  major	  presynaptic	  proteins	  that	  are	  localized	  in	   or	   associated	   with	   presynaptic	   vesicles	   (Elferink	   and	   Scheller,	   1995;	   Schoch	   and	  Gundelfinger,	   2006;	   Shin,	   2014;	   Wiedenmann	   and	   Franke,	   1985).	   On	   the	   other	   hand,	  SynGAP	  and	  PSD95	  are	  two	  major	  postsynaptic	  proteins	  that	  are	  enriched	  at	  postsynaptic	  sites	   of	   excitatory	   synapses,	   where	   they	   critically	   help	   organizing	   and	   strengthening	  excitatory	   receptor	   complexes	   and	   their	   associated	   signaling	   proteins	   (Kim	   et	   al.,	   1998;	  Kim	  and	  Sheng,	  2004;	  Sheng	  and	  Hoogenraad,	  2007).	  Microglia	  density	  was	  examined	  by	  
6	  
	  
quantification	  of	  cells	  immunoreactive	  for	  the	  ionized	  calcium-­‐binding	  adaptor	  molecule	  1	  (Iba1),	   whereas	   their	   activation	   status	   was	   assessed	   through	   the	   analysis	   of	   microglia	  morphology	   and	   cluster	   of	   differentiation	   68	   (CD68)	   immunoreactivity	   (Colton	   and	  Wilcock,	   2010;	   Franco	   and	   Fernández-­‐Suárez,	   2015;	   Ransohoff	   and	   Perry,	   2015).	   In	  addition,	   we	   measured	   the	   density	   of	   glial	   fibrillary	   acidic	   protein	   (GFAP)-­‐positive	  astrocytes	  and	  the	   levels	  of	  cytokines	   in	  plasma	  and	  hippocampus	  to	  assess	  the	  effects	  of	  prenatal	   immune	   activation	   on	   astrogliosis	   and	   inflammatory	   signaling,	   respectively.	   To	  confirm	   the	   negative	   influence	   of	   prenatal	   immune	   challenge	   on	   behavior,	  we	  measured	  sensorimotor	  gating	  using	  the	  paradigm	  of	  prepulse	  inhibition	  (PPI)	  of	  the	  acoustic	  startle	  reflex.	   PPI	   deficiency	   is	   a	   well-­‐replicated	   behavioral	   manifestation	   emerging	   in	   rats	   and	  mice	  exposed	  to	  prenatal	  immune	  activation	  (for	  a	  review,	  see	  Boksa,	  2010;	  Meyer,	  2014;	  Meyer	   and	   Feldon,	   2010;	   Reisinger	   et	   al.,	   2015)	   and	   is	   frequently	   observed	   in	  neuropsychiatric	   disorders	   with	   neurodevelopmental	   components	   (Braff	   et	   al.,	   2001;	  Swerdlow	  et	  al.,	  2008).	  All	  analyses	  were	  conducted	  during	  puberty	  and	  adulthood	  in	  order	  to	  identify	  possible	  maturation-­‐dependent	  effects	  of	  prenatal	  immune	  activation.	  	  	  
2.	  Methods	  
2.1.	  Animals	  C57BL6/N	  mice	  were	  used	  throughout	  the	  study.	  Female	  and	  male	  breeders	  were	  obtained	  from	  Charles	  River	  Laboratories	  (Sulzfeld,	  Germany)	  at	   the	  age	  of	  10–14	  weeks.	  Breeding	  began	   after	   2	   weeks	   of	   acclimatization	   to	   the	   animal	   holding	   rooms,	   which	   were	  temperature-­‐	  and	  humidity-­‐controlled	  (21	  ±	  1°C,	  55	  ±	  5%)	  facilities	  under	  a	  reversed	  light–dark	  cycle.	  All	  animals	  had	  ad	  libitum	  access	  to	  food	  (Kliba	  3430,	  Kaiseraugst,	  Switzerland)	  
7	  
	  
and	  water.	  All	  procedures	  described	  in	  the	  present	  study	  had	  been	  previously	  approved	  by	  the	  Cantonal	  Veterinarian's	  Office	  of	  Zurich.	  All	  efforts	  were	  made	  to	  minimize	  the	  number	  of	  animals	  used	  and	  their	  suffering.	  
	  
2.2.	  Maternal	  immune	  activation	  during	  pregnancy	  For	  the	  purpose	  of	  the	  maternal	  immune	  challenge,	  C57BL6/N	  female	  mice	  were	  subjected	  to	  a	  timed	  mating	  procedure	  as	  described	  previously	  (Meyer	  et	  al.,	  2005).	  Pregnant	  dams	  on	  gestation	   day	   (GD)	   9	   were	   randomly	   assigned	   to	   receiving	   either	   a	   single	   injection	   of	  poly(I:C)	  (potassium	  salt;	  Sigma-­‐Aldrich,	  Buchs,	  St.	  Gallen,	  Switzerland)	  or	  vehicle.	  Poly(I:C)	  (5	  mg/kg;	   calculated	  based	  on	   the	  pure	   form	  poly(I:C))	  was	  dissolved	   in	   sterile	  pyrogen-­‐free	   0.9%	   NaCl	   (vehicle)	   solution	   to	   yield	   a	   final	   concentration	   of	   1	   mg/ml	   and	   was	  administered	  intravenously	  (i.v.)	  into	  the	  tail	  vein	  under	  mild	  physical	  constraint.	  The	  dose	  of	  poly(I:C)	  was	  selected	  based	  on	  previous	  dose-­‐response	  studies	  (Meyer	  et	  al.,	  2005).	  A	  total	   of	   16	   pregnant	   dams	   were	   used,	   half	   of	   which	   were	   allocated	   to	   the	   poly(I:C)	  treatment,	  and	  the	  other	  half	  to	  the	  vehicle	  treatment.	  	  	   The	  selected	  gestational	  window	  (i.e.,	  GD	  9)	  in	  mice	  corresponds	  roughly	  to	  the	  middle	  of	   the	   first	   trimester	   of	   human	   pregnancy	   with	   respect	   to	   developmental	   biology	   and	  percentage	  of	  gestation	  from	  mice	  to	  humans	  (Clancy	  et	  al.,	  2007).	  It	  was	  selected	  based	  on	  our	  previous	  findings	  showing	  that	  poly(I:C)	  exposure	  on	  GD	  9	  leads	  to	  multiple	  behavioral	  abnormalities	  in	  the	  adult	  offspring,	  including	  deficits	  in	  PPI	  (Meyer	  et	  al.,	  2005,	  2006).	  We	  have	   also	   verified	   the	   effectiveness	   of	   this	   poly(I:C)	   administration	   protocol	   in	   mice	   in	  terms	   of	   the	   elicited	   cytokine-­‐associated	   inflammatory	   response	   in	   maternal	   and	   fetal	  tissues	  (e.g.,	  Meyer	  et	  al.,	  2006).	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2.3.	  Allocation	  and	  testing	  of	  the	  offspring	  All	  offspring	  were	  weaned	  and	  sexed	  on	  postnatal	  day	  (PND)	  21.	  Littermates	  of	   the	  same	  sex	  were	   caged	   separately	   and	  maintained	   in	   groups	   of	   3-­‐5	   animals	   per	   cage.	   Only	  male	  animals	  were	   included	   in	   all	   experiments.	   Poly(I:C)	   and	   control	   offspring	   stemmed	   from	  multiple	   independent	   litters	   (N	   =	   8	   for	   each	   prenatal	   treatment	   group)	   to	   avoid	   possible	  confounds	   arising	   from	   litter	   effects.	   For	   each	   maturational	   stage	   (i.e.,	   pubescence	   and	  adulthood),	   1	  male	   offspring	   per	   litter	  was	   randomly	   selected	   for	   the	   initial	   PPI	   test	   and	  subsequent	   immunohistochemical	   evaluations	   of	   glial	   and	   synaptic	  markers,	   leading	   to	   a	  group	  size	  of	  N=8	  offspring	  per	  treatment	  group	  and	  age.	  Pubescent	  and	  adult	  testing	  began	  with	  the	  assessment	  of	  PPI	  on	  PND	  35	  and	  PND	  84,	  respectively.	  Following	  a	  resting	  period	  of	  5-­‐6	  days,	  the	  animals	  were	  then	  sacrificed	  on	  PND	  40	  and	  PND	  90,	  respectively,	  for	  the	  purpose	  of	  the	  immunohistochemical	  evaluations	  in	  pubescence	  and	  adulthood.	  	   The	  remaining	  offspring	  from	  poly(I:C)	  and	  control	  litters	  were	  used	  for	  the	  analysis	  of	  plasma	   and	   hippocampal	   cytokines	   in	   pubescence	   (N	  =	  10	   per	   treatment	   group)	   and	   in	  adulthood	  (N	  =	  8	  per	  treatment	  group).	  The	  animals	  were	  killed	  on	  PND	  40	  and	  PND	  90	  to	  match	   the	   age	   of	   those	   offspring,	   which	   were	   assigned	   to	   the	   immunohistochemical	  evaluations	  of	  glial	  and	  synaptic	  markers.	  	   The	  pubescent	  and	  adult	  stages	  were	  defined	  based	  on	  the	  gradual	  attainment	  of	  sexual	  maturity	  and	  age-­‐specific	  behavioral	  discontinuities	  from	  younger	  to	  older	  animals	  (Spear,	  2000)	   and	  based	   on	   our	   previous	   findings	   revealing	   a	   post-­‐pubertal	   onset	   of	   PPI	   deficits	  following	  poly(I:C)-­‐induced	  prenatal	  immune	  activation	  in	  mice	  (Vuillermot	  et	  al.,	  2010).	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2.4.	  Prepulse	  inhibition	  of	  the	  acoustic	  startle	  reflex	  Sensorimotor	   gating	  was	   assessed	  using	   the	  paradigm	  of	   prepulse	   inhibition	   (PPI)	   of	   the	  acoustic	   startle	   reflex.	   PPI	   of	   the	   acoustic	   startle	   reflex	   refers	   to	   the	   reduction	   in	   startle	  reaction	   in	   response	   to	   a	   startle-­‐eliciting	  pulse	   stimulus	  when	   it	   is	   shortly	  preceded	  by	  a	  weak	  prepulse	  stimulus	  (Braff	  et	  al.,	  2001;	  Swerdlow	  et	  al.,	  2008).	  The	  apparatus	  consisted	  of	  four	  startle	  chambers	  for	  mice	  (San	  Diego	  Instruments,	  San	  Diego,	  CA,	  USA)	  and	  has	  been	  fully	   described	   elsewhere	   (Meyer	   et	   al.,	   2005).	   In	   the	   demonstration	   of	   PPI,	   the	   animals	  were	  presented	  with	  a	  series	  of	  discrete	  trials	  comprising	  a	  mixture	  of	  4	  trial	  types.	  These	  included	   pulse-­‐alone	   trials,	   prepulse-­‐plus-­‐pulse	   trials,	   prepulse-­‐alone	   trials,	   and	   no-­‐stimulus	  trials	  in	  which	  no	  discrete	  stimulus	  other	  than	  the	  constant	  background	  noise	  was	  presented.	  The	  pulse	  and	  prepulse	  stimuli	  used	  were	  in	  the	  form	  of	  a	  sudden	  elevation	  in	  broadband	   white	   noise	   level	   (sustaining	   for	   40	   and	   20	   ms,	   respectively)	   from	   the	  background	  (65	  dBA),	  with	  a	  rise	  time	  of	  0.2–1.0	  ms.	  In	  all	  trials,	  three	  different	  intensities	  of	   pulse	   (100,	   110,	   and	   120	   dBA)	   and	   three	   intensities	   of	   prepulse	   (71,	   77,	   and	   83	   dBA,	  which	  corresponded	  to	  6,	  12,	  and	  18	  dBA	  above	  background,	  respectively)	  were	  used.	  The	  stimulus-­‐onset	   asynchrony	   of	   the	   prepulse	   and	   pulse	   stimuli	   on	   all	   prepulse-­‐plus-­‐pulse	  trials	  was	  100	  ms	  (onset-­‐to-­‐onset).	  	   The	  protocol	  used	  for	  the	  PPI	  test	  was	  extensively	  validated	  before	  (e.g.,	  Vuillermot	  et	  al.,	  2010).	  A	  session	  began	  with	  the	  animals	  being	  placed	  into	  the	  Plexiglas	  enclosure.	  They	  were	  acclimatized	  to	  the	  apparatus	  for	  2	  min	  before	  the	  first	  trial	  began.	  The	  first	  6	  trials	  consisted	  of	  6	  startle-­‐alone	  trials;	  such	  trials	  served	  to	  habituate	  and	  stabilize	  the	  animals’	  startle	   response	   and	   were	   not	   included	   in	   the	   analysis.	   Subsequently,	   the	   animals	   were	  presented	  with	  10	  blocks	  of	  discrete	  test	  trials.	  Each	  block	  consisted	  of	  the	  following:	  three	  pulse-­‐alone	  trials	  (100,	  110,	  or	  120	  dBA),	  3	  prepulse-­‐alone	  trials	  (+6,	  +12,	  or	  +18	  dBA	  above	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background),	   9	   possible	   combinations	   of	   prepulse-­‐plus-­‐pulse	   trials	   (3	   levels	   of	   pulse × 3	  levels	  of	  prepulse),	  and	  one	  no	  stimulus	  trial.	  The	  16	  discrete	  trials	  within	  each	  block	  were	  presented	   in	  a	  pseudorandom	  order,	  with	  a	  variable	   interval	  of	  15	  s	  on	  average	   (ranging	  from	  10	  to	  20	  s).	  For	  each	  of	  the	  3	  pulse	  intensities	  (100,	  110,	  or	  120	  dBA),	  PPI	  was	  indexed	  by	   percent	   inhibition	   of	   the	   startle	   response	   obtained	   in	   the	   pulse-­‐alone	   trials	   by	   the	  following	   expression:	   100% × [1 − (mean	   reactivity	   on	   prepulse-­‐plus-­‐pulse	   trials/mean	  reactivity	  on	  pulse-­‐alone	  trials)],	  for	  each	  animal,	  and	  at	  each	  of	  the	  three	  possible	  prepulse	  intensities	  (+6,	  +12,	  or	  +18	  dBA	  above	  background).	  In	  addition	  to	  PPI,	  reactivity	  to	  pulse-­‐alone	  trials	  and	  prepulse-­‐alone	  trials	  were	  also	  analyzed.	  	  
2.5.	  Immunohistochemistry	  The	  animals	  were	  deeply	  anesthetized	  with	  an	  overdose	  of	  Nembutal	  (Abbott	  Laboratories,	  North	   Chicago,	   IL,	   USA)	   and	   perfused	   transcardially	   with	   0.9%	   NaCl,	   followed	   by	   4%	  phosphate-­‐buffered	  paraformaldehyde	   solution	   containing	  15%	  picric	   acid.	  The	  dissected	  brains	   were	   postfixed	   in	   the	   same	   fixative	   for	   6	   h	   and	   processed	   for	   antigen	   retrieval	  involving	  overnight	  incubation	  in	  citric	  acid	  buffer	  (pH	  4.5)	  followed	  by	  a	  90	  s	  microwave	  treatment	   at	   480	   W	   according	   to	   protocols	   established	   before	   (Giovanoli	   et	   al,	   2013;	  Vuillermot	   et	   al.,	   2010).	   The	   brains	  were	   then	   cryoprotected	   using	   30%	   sucrose	   in	   PBS,	  frozen	  with	  powdered	  dry	  ice,	  and	  stored	  at	  −80°C	  until	  further	  processing.	  	   Perfused	  brain	  samples	  were	  cut	  coronally	  at	  30	  μm	  thickness	  from	  frozen	  blocks	  with	  a	  sliding	  microtome.	  Eight	  serial	  sections	  were	  prepared	  for	  each	  animal	  and,	  after	  rinsing	  in	  PBS,	  stored	  at	  −20°C	  in	  antifreeze	  solution	  (30%	  glycerol	  and	  30%	  ethylene	  glycol	  in	  PBS	  at	  25	  mM	  and	  pH	  7.4)	  until	  further	  processing.	  For	  immunohistochemical	  staining,	  the	  slices	  were	  rinsed	  three	  times	  for	  10	  min	  in	  PBS,	  and	  blocking	  was	  done	  in	  PBS,	  0.3%	  Triton	  X-­‐
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100,	   10%	  normal	   serum	   for	   1	   h	   at	   room	   temperature.	   The	   following	   primary	   antibodies	  were	  used:	  Rabbit	  anti-­‐Iba1	  (Wako,	  Neuss,	  Germany;	  diluted	  1:2,000),	  rat	  anti-­‐CD68	  (AbD	  Serotec,	   Oxford,	   UK;	   diluted	   1:5,000),	   rabbit	   anti-­‐GFAP	   (Dako,	   Baar,	   Switzerland;	   diluted	  1:5,000),	   rabbit	   anti-­‐synaptophysin	   (Sigma,	   diluted	   1:3,000),	   mouse	   anti-­‐bassoon	  (Stressgen	   Biotechnologies,	   Victoria,	   Canada;	   diluted	   1:5,000),	   mouse	   anti-­‐PSD95	   (Pierce	  Antibody	  Products,	  diluted	  1:800),	  and	  rabbit	  anti-­‐SynGap	  (Affinity	  BioReagents,	  Colorado,	  USA;	   diluted	   1:400).	   All	   primary	   antibodies	  were	   validated	   before	   (Giovanoli	   et	   al,	   2013;	  Nyffeler	  et	  al.,	  2006,	  2007).	  They	  were	  diluted	  in	  PBS	  containing	  0.3%	  Triton	  X-­‐100	  and	  2%	  normal	   serum,	   and	   the	   sections	   were	   incubated	   free-­‐floating	   overnight	   at	   room	  temperature.	  After	  three	  washes	  with	  PBS	  (10	  min	  each),	  the	  sections	  were	  incubated	  for	  1	  h	  with	  the	  biotinylated	  secondary	  antibodies	  diluted	  1:500	  in	  PBS	  containing	  2%	  NGS	  and	  0.3%	   Triton	   X-­‐100.	   Sections	   were	   washed	   again	   three	   times	   for	   10	   min	   in	   PBS	   and	  incubated	  with	  Vectastain	  kit	  (Vector	  Laboratories,	  Burlingame,	  CA,	  USA)	  diluted	  in	  PBS	  for	  1	  h.	  After	  three	  rinses	  in	  0.1	  M	  Tris-­‐HCl,	  pH	  7.4,	  the	  sections	  were	  stained	  with	  1.25%	  3,3-­‐diaminobenzidine	   and	   0.08%	   H2O2	   for	   10–15	   min,	   rinsed	   again	   four	   times	   in	   PBS,	  dehydrated,	  and	  coverslipped	  with	  Eukitt	  (Kindler,	  Freiburg,	  Germany).	  	  
2.6.	  Unbiased	  stereological	  estimations	  The	  numbers	  of	  Iba1-­‐,	  CD68-­‐,	  or	  GFAP-­‐immunoreactive	  cells	  were	  determined	  by	  unbiased	  stereological	   estimations	   using	   the	   optical	   fractionator	  method	   (Gundersen	   et	   al.,	   1988).	  With	  the	  aid	  of	   the	   image	  analysis	  computer	  software	  Stereo	  Investigator	  (version	  6.50.1;	  MicroBrightField,	  Williston,	  VT,	  USA),	  every	  section	  of	  a	  one-­‐in-­‐eight	  series	  was	  measured,	  resulting	   in	   an	   average	   of	   4-­‐5	   sections	   per	   brain	   sample.	   The	   following	   sampling	  parameters	  were	  used:	  (1)	  a	  fixed	  counting	  frame	  with	  a	  width	  of	  60	  μm	  and	  a	  length	  of	  60	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μm;	   and	   (2)	   a	   sampling	   grid	   size	   of	   200	   ×	   150	   μm.	   The	   counting	   frames	   were	   placed	  randomly	   at	   the	   intersections	   of	   the	   grid	  within	   the	   outlined	   structure	   of	   interest	   by	   the	  software.	   The	   cells	  were	   counted	   following	   the	   unbiased	   sampling	   rule	   using	   the	   40×	   oil	  lens	  [numerical	  aperture	  (NA),	  1.3]	  and	  included	  in	  the	  measurement	  when	  they	  came	  into	  focus	   within	   the	   optical	   dissector	   (Howard	   and	   Reed,	   2005).	   All	   immunohistochemical	  preparations	  were	  quantified	  in	  the	  dorsal	  cornu	  amonis	  1	  to	  3	  (CA1	  –CA3)	  regions	  of	  the	  hippcoampus	   (Bregma	   -­‐1.3	   to	   -­‐2.7	   mm),	   thereby	   including	   stratum	   oriens	   (so),	   stratum	  radiatum	   (sr),	   and	   stratum	   lacunosum	   moleculare	   (slm).	   Preliminary	   analyses	   have	  revealed	  no	   layer-­‐specific	  effects	  of	  prenatal	   immune	  activation	  (data	  not	  shown),	  so	   that	  the	   data	   representing	   the	   entire	   dorsal	   CA	   region	   are	   presented.	   In	   addition,	   the	  immunohistochemical	  preparations	  were	  quantified	  in	  the	  dorsal	  stratum	  moleculare	  (sm)	  of	  the	  dentate	  gyrus	  (DG;	  Bregma	  -­‐1.3	  to	  -­‐2.7	  mm).	  In	  view	  of	  the	  dorsal-­‐ventral	  dichotomy	  of	  the	  hippocampus,	  we	  extended	  parts	  of	  the	  stereological	  estimations	  to	  the	  ventral	  part	  of	   the	  hippocampus	   (Bregma	   -­‐2.9	   to	   -­‐3.5	  mm),	   thereby	   including	   the	   same	  ventral	   layers	  (CA:	   so,	   sr,	   slm;	   DG:	   sm)	   as	   for	   the	   dorsal	   subregion.	   All	   brain	   regions	   and	   layers	   were	  delineated	  according	  to	  the	  “Mouse	  Brain	  in	  Stereotaxic	  Coordinates”	  (Franklin	  and	  Paxinos,	  2008).	   These	   stereological	  methods	  were	  previously	   validated	   to	   capture	   overt	  microglia	  anomalies	  under	  conditions	  of	  hippocampal	  inflammation	  (Giovanoli	  et	  al.,	  2013).	  	  
2.7.	  Assessment	  of	  microglia	  morphology	  Iba1-­‐immunoreactive	  microglia	  were	  visualized	  under	  the	  63×	  oil	  lens	  [numerical	  aperture	  (NA),	   1.4]	   using	   a	   Zeiss	   Axiophot	   microscope	   (Carl	   Zeiss,	   Jena,	   Germany).	   Various	  parameters	   of	   microglia	   cell	   morphology	   were	   assessed	   in	   the	   CA1	   slm	   and	   DG	   sm	  according	  to	  methods	  described	  before	  (Giovanoli	  et	  al.,	  2013).	  In	  brief,	  a	  counting	  frame	  of	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100	   μm	   ×	   100	   μm	  was	   randomly	   placed	   into	   three	   sections	   of	   a	   one-­‐in-­‐eight	   series.	   All	  microglia	   cells	   captured	   by	   the	   counting	   frame	   were	   included	   in	   the	   morphological	  analyses,	  except	  when	  microglial	  processes	  were	  obscured	  by	  either	  background	  labeling	  or	  other	  cells.	  3	  to	  4	  microglia	  cells	  in	  every	  section	  of	  a	  one-­‐in-­‐eight	  series	  (see	  above)	  were	  traced	  using	  the	  software	  Stereo	  Investigator	  (version	  6.50.1;	  MicroBrightField),	  for	  which	  cell	  soma	  area	  and	  the	  number	  of	  primary	  and	  secondary	  processes	  were	  estimated,	  giving	  a	  total	  of	  12	  to	  16	  cells	  per	  animal,	  as	  described	  before	  (Giovanoli	  et	  al.,	  2013).	  
	  
2.8.	  Optical	  densitometry	  Quantification	   of	   synaptophysin,	   bassoon,	   PSD95,	   and	   SynGap	   immunoreactivity	   was	  achieved	  by	  means	  of	  optical	  densitometry	  using	  NIH	  ImageJ	  software	  as	  described	  before	  (Giovanoli	   et	   al,	   2013;	   Nyffeler	   et	   al.,	   2007).	   In	   brief,	   digital	   images	   were	   acquired	   at	   a	  magnification	  of	  5.0×	  using	  a	  digital	  camera	  (Axiocam	  MRc5;	  Carl	  Zeiss)	  mounted	  on	  a	  Zeiss	  Axioplan	  microscope.	  Exposure	  times	  were	  set	  so	  that	  pixel	  brightness	  was	  never	  saturated.	  Pixel	   brightness	   was	   measured	   in	   the	   respective	   areas	   of	   one	   randomly	   selected	   brain	  hemisphere.	   In	   addition,	   pixel	   brightness	  was	  measured	   in	   non-­‐immunoreactive	   areas	   of	  the	   corpus	   callosum	   as	   background	   measurements.	   The	   background-­‐corrected	   relative	  optical	  densities	  were	  averaged	  per	  brain	  region	  and	  animal.	  Four	  to	  5	  sections	  per	  animal	  were	   analyzed	   for	   each	   brain	   region	   of	   interest.	   All	   immunohistochemical	   preparations	  were	   quantified	   in	   the	   dorsal	   CA	   and	  DG	   regions	   (Bregma	   -­‐1.3	   to	   -­‐2.7	  mm)	   as	   described	  above.	   Synaptophysin	   and	   PSD95	   immunoreactivities	  were	   also	   quantified	   in	   the	   ventral	  subregions	   of	   the	   hippocampus	   (Bregma	   -­‐2.9	   to	   -­‐3.5	   mm),	   thereby	   including	   the	   same	  layers	  (CA:	  so,	  sr,	  slm;	  DG:	  sm)	  as	  for	  the	  dorsal	  subregions.	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2.9.	  Preparation	  of	  plasma	  samples	  and	  hipocampal	  homogenates	  Mice	   were	   killed	   by	   decapitation	   and	   trunk	   blood	   was	   collected	   in	   heparinized	   tubes	  (Microvette	   CB	  300	   LH,	   Sarstedt,	   Nümbrecht,	   Germany).	   Plasma	   was	   separated	   by	  centrifugation	  (2000	  ×	  g,	  5	  min)	  and	  stored	  at	  −20°C	  until	   later	  analyses.	  The	  brains	  were	  extracted	  from	  the	  skull	  and	  placed	  ventral	  side	  up	  on	  an	  ice-­‐chilled	  plate	  for	  extraction	  of	  the	   left	   and	   right	   hippocampi.	   The	   entire	   hippocampi	  were	  weighed	   and	   stored	   at	   −80°C	  until	   further	   processing.	   Frozen	   hippocampal	   samples	  were	   placed	   in	   300	   μl	   lysis	   buffer	  containing	   50	  mM	  Tris-­‐HCl	   (pH	  7.4),	   0.6	  M	  NaCl,	   0.2%	  Triton	  X-­‐100,	   0.5%	  bovine	   serum	  albumin,	  and	  protease	  inhibitors	  (1	  mM	  benzamidine,	  0.1	  mM	  benzethonium	  chloride	  and	  0.1	   mM	   phenylmethylsulfonyl	   fluoride).	   Once	   placed	   in	   the	   lysis	   buffer,	   samples	   were	  allowed	  to	  thaw	  and	  were	  then	  homogenized	  (TissueTearor;	  BioSpec	  Products,	  Bartlesville,	  OK,	  USA)	  for	  10	  s,	  sonicated	  (Vibra	  Cell;	  Sonics	  &	  Materials,	  Newtown,	  CT,	  USA)	  for	  20	  s	  at	  10	   mV,	   and	   centrifuged	   as	   described	   before	   (Giovanoli	   et	   al.,	   2013).	   The	   hippocampal	  supernatants	  were	  aliquoted	  and	  frozen	  at	  –80°C	  until	  the	  cytokine	  assays	  were	  performed	  (see	  below).	  
	  
2.10.	  Cytokine	  assay	  Cytokine	   levels	   in	   plasma	   and	   hippocampal	   supernatants	   were	   quantified	   using	   a	  customized	  Meso-­‐Scale	  Discovery	  (MSD)	  V-­‐Plex	  electrochemiluminescence	  assay	   for	  mice,	  which	  allows	  ultralow	  detection	  of	  multiple	   cytokines	   in	  mouse	  plasma	  and	  supernatants	  (Burguillos,	   2013).	   V-­‐plex	   plus	   96-­‐well	   plates	   coated	   with	   primary	   antibodies	   directed	  against	   interleukin	   (IL)-­‐1β,	   IL-­‐4,	   IL-­‐6,	   and	   tumor	   necrosis	   factor	   (TNF)-­‐α	  were	   used	   and	  were	   treated	   with	   the	   corresponding	   detecting	   antibodies,	   which	   were	   prelabeled	   with	  SULFO-­‐TAGTM	  (MSD,	  Rockville,	  Maryland,	  USA).	  The	  plates	  were	  read	  using	  the	  SECTOR	  PR	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400	  (MSD)	  imager	  and	  analyzed	  using	  MSD’s	  Discovery	  Workbench	  analyzer	  and	  software	  package.	  All	  assays	  were	  run	  according	  to	  the	  manufacturer’s	   instructions.	  IL-­‐1β,	  IL-­‐6	  and	  TNF-­‐α	   were	   selected	   to	   cover	   prototypical	   pro-­‐inflammatory	   cytokines	   secreted	   by	  classically	   activated	   (M1)	   microglia,	   and	   IL-­‐4	   was	   selected	   to	   probe	   a	   prototypical	   anti-­‐inflammatory	  cytokine	  inducing	  alternative	  (M2)	  microglia	  activation	  (Cherry	  et	  al.,	  2014).	  The	  detection	  limits	  were	  0.04	  pg/ml	  for	  IL-­‐1β,	  0.06	  pg/ml	  for	  IL-­‐4,	  0.5	  pg/ml	  for	  IL-­‐6,	  and	  0.03	  pg/ml	  for	  TNF-­‐α.	  To	  express	  hippocampal	  cytokine	  levels,	  the	  cytokine	  concentrations	  quantified	   in	   the	   corresponding	   hippocampal	   lysates	   were	   normalized	   to	   the	   animals’	  hippocampal	  weights	  measured	  immediately	  after	  hippocampal	  dissection.	  	  
2.11.	  Statistical	  analyses	  All	   data	   were	   analyzed	   using	   full-­‐factorial	   parametric	   analysis	   of	   variance	   (ANOVA),	  followed	  by	  Fisher's	   least	   significant	  difference	   (LSD)	  post-­‐hoc	   comparisons	  or	   restricted	  ANOVAs	  whenever	  appropriate.	  Percent	  PPI	  was	  analyzed	  using	  a	  2	  ×	  2	  ×	  3	  ×	  3	  (prenatal	  treatment	  ×	  age	  ×	  prepulse	  level	  ×	  pulse	  level)	  ANOVA,	  and	  reactivities	  to	  pulse-­‐alone	  trials	  and	  prepulse-­‐alone	  trials	  were	  analyzed	  using	  2	  ×	  2	  ×	  3	  	  (prenatal	  treatment	  ×	  age	  ×	  pulse	  level)	  and	  2	  ×	  2	  ×	  3	  (prenatal	  treatment	  ×	  age	  ×	  prepulse	   level)	  ANOVAs,	  respectively.	  All	  immunohistochemical	  and	  cytokine	  data	  were	  analyzed	  using	  a	  2	  ×	  2	  (prenatal	  treatment	  ×	  age)	   ANOVA.	   Statistical	   significance	   was	   set	   at	   p	   <	   0.05.	   All	   statistical	   analyses	   were	  performed	  using	  the	  statistical	  software	  StatView	  software	  (version	  5.0)	  implemented	  on	  a	  PC	  running	  the	  Windows	  XP	  operating	  system.	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3.	  Results	  	  
3.1.	  Prenatal	  immune	  activation	  induces	  an	  adult	  onset	  of	  prepulse	  inhibition	  deficits	  Consistent	  with	  previous	  reports	  (Lipina	  et	  al.,	  2013;	  Vuillermot	  et	  al.,	  2010),	  we	  found	  that	  poly(I:C)-­‐induced	   prenatal	   immune	   activation	   induced	   an	   adult	   onset	   of	   PPI	   deficits	  (Fig.1A).	   ANOVA	   yielded	   a	   significant	   main	   effect	   of	   age	   [F(1,28)	   =	   136.75,	   p	   <	   0.001],	  reflecting	  the	  general	  increase	  in	  %	  PPI	  displayed	  by	  adult	  relative	  to	  pubescent	  animals,	  as	  well	   as	   a	   significant	   interaction	  between	   age	   and	  prenatal	   treatment	   [F(1,28)	   =	   4.80,	  p	   <	  0.05].	   Subsequent	   post-­‐hoc	   analyses	   verified	   that	   adult	   but	   not	   pubescent	   offspring	   of	  poly(I:C)-­‐exposed	  mothers	  displayed	  a	  significant	  (p	  <	  0.05)	  reduction	  in	  %PPI	  compared	  to	  adult	  control	  offspring	  (Fig.	  1A).	  	  	   Prenatal	   immune	   activation	   did	   not	   significantly	   affect	   the	   reactivity	   to	   pulse-­‐alone	  trials	  (Fig.	  1B)	  or	  prepulse-­‐alone	  trials	  (Fig.	  1C).	  For	  both	  measures,	  ANOVA	  only	  revealed	  a	  significant	  main	  effect	  of	  age	  [pulse:	  F(1,28)	  =	  5.25,	  p	  <	  0.05;	  prepulse:	  F(1,28)	  =	  59.80,	  p	  <	  0.001],	   reflecting	   the	   general	   increases	   in	   pulse-­‐	   or	   prepulse-­‐induced	   reactivity	   from	  pubescence	  to	  adulthood.	  
	  
3.2.	   Prenatal	   immune	   activation	   induces	   an	   adult	   onset	   of	   presynaptic	   hippocampal	  
deficits	  As	  depicted	   in	  Fig.	   2A,	   the	  relative	  density	  of	   the	  presynaptic	  marker	  synaptophysin	  was	  generally	  increased	  in	  the	  dorsal	  CA	  and	  DG	  of	  adult	  relative	  to	  pubescent	  mice,	  leading	  to	  a	  significant	  main	  effect	  of	  age	  [CA:	  F(1,28)	  =	  44.87,	  p	  <	  0.001;	  DG:	  F(1,28)	  =	  47.94,	  p	  <	  0.001].	  Adult	   (but	   not	   pubescent)	   offspring	   of	   poly(I:C)-­‐exposed	  mothers	   displayed	   a	   significant	  decrease	  in	  the	  relative	  density	  of	  synaptophysin	  compared	  to	  adult	  control	  offspring.	  This	  effect	   emerged	   similarly	   in	   the	   dorsal	   CA	   and	   DG	   (Fig.	   2A,B)	   and	  was	   supported	   by	   the	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significant	   interaction	  between	  prenatal	   treatment	   and	   age	   [CA:	  F(1,28)	   =	   8.64,	  p	   <	   0.01;	  DG:	  F(1,28)	  =	  5.95,	  p	  <	  0.05],	  and	  by	  the	  subsequent	  post-­‐hoc	  comparisons	  confirming	  the	  significant	  group	  differences	  in	  adulthood	  (for	  both	  CA	  and	  DG,	  p	  <	  0.05).	  Similar	  findings	  were	   obtained	   with	   regards	   to	   synaptophysin	   expression	   in	   the	   ventral	   CA	   and	   DG	  subregions	  (Suppl.	  Fig.	  S1).	  	   In	  contrast	  to	  synaptophysin,	  the	  density	  of	  the	  presynaptic	  marker	  bassoon	  generally	  decreased	   from	  pubescence	   to	   adulthood	   (Fig.	   2C),	   leading	   to	   a	   significant	  main	  effect	  of	  age	   [CA:	   F(1,28)	   =	   76.18,	   p	   <	   0.001;	   DG:	   F(1,28)	   =	   86.80,	   p	   <	   0.001].	   Prenatal	   immune	  activation	  significantly	  reduced	  the	  relative	  density	  of	  bassoon	  in	  the	  dorsal	  CA	  and	  DG	  of	  adult	   but	  not	  pubescent	   offspring	   (Fig.	   2C,D),	   as	   supported	  by	   the	   significant	   interaction	  between	  prenatal	   treatment	  and	  age	  [CA:	  F(1,28)	  =	  5.84,	  p	  <	  0.05;	  DG:	  F(1,28)	  =	  7.29,	  p	  <	  0.01].	  Subsequent	  post-­‐hoc	  comparisons	  verified	  the	  significant	  group	  differences	  in	  adult	  offspring	  (for	  both	  CA	  and	  DG,	  p	  <	  0.01).	  	  	  
3.3.	   Prenatal	   immune	   activation	   induces	   a	   pubescent	   onset	   of	   postsynaptic	  
hippocampal	  deficits	  The	   relative	   density	   of	   the	   postsynaptic	   protein	   PSD95	   in	   both	   the	   dorsal	   CA	   and	   DG	  generally	  decreased	   from	  pubescence	   to	  adulthood,	   leading	   to	  a	   significant	  main	  effect	  of	  age	  [CA:	  F(1,28)	  =	  27.87,	  p	  <	  0.001;	  DG:	  F(1,28)	  =	  36.98,	  p	  <	  0.001].	  Offspring	  of	  poly(I:C)-­‐exposed	  mothers	  displayed	  a	  significant	  reduction	  of	  PSD95	  in	  the	  dorsal	  CA	  and	  DG.	  This	  effect	   was	   already	   present	   in	   pubescence	   and	   persisted	   into	   adulthood	   (Fig.	   3A,B),	   as	  supported	   by	   the	   significant	  main	   effect	   of	   prenatal	   treatment	   [CA:	   F(1,28)	   =	   23.99,	   p	   <	  0.001;	  DG:	  F(1,28)	  =	  32.19,	  p	  <	  0.001].	  Prenatal	  immune	  activation	  led	  to	  a	  similar	  reduction	  in	  PSD95	  expression	  in	  the	  ventral	  CA	  and	  DG	  subregions,	  which	  was	  evident	  in	  pubescent	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and	  adult	  offspring	  of	  poly(I:C)-­‐exposed	  offspring	  relative	  to	  age-­‐matched	  controls	  (Suppl.	  
Fig.	  S2).	  	  	  	   In	   addition	   to	   its	   age-­‐independent	   effect	   on	   PSD95	   (Fig.	   3A,B),	   prenatal	   immune	  activation	  also	  reduced	  the	  relative	  density	  of	  the	  postsynaptic	  protein	  SynGap.	  In	  contrast	  to	   PSD95,	   however,	   prenatal	   poly(I:C)	   treatment	   selectively	   decreased	   SynGap	   density	   in	  the	  dorsal	  CA	  region	  at	  pubescent	  but	  not	  adult	  age	  (Fig.	  3C,D).	  This	  age-­‐dependent	  effect	  in	  the	   dorsal	   CA	   region	   was	   supported	   by	   the	   significant	   interaction	   between	   prenatal	  treatment	   and	   age	   [F(1,28)	   =	   6.93,	   p	   <	   0.05],	   and	   by	   the	   subsequent	   post-­‐hoc	   analysis	  confirming	  the	  significant	  group	  difference	  in	  pubescent	  animals	  (p	  <	  0.01).	  No	  significant	  effects	  were	  obtained	  with	  regards	  to	  SynGAP	  density	  in	  the	  dorsal	  DG.	  	  
	  
3.4.	   Prenatal	   immune	   activation	   does	   not	   alter	   hippocampal	   microglia	   density	   or	  
activation	  statuses	  	  Unbiased	  stereological	  estimations	  of	  Iba1-­‐positive	  microglia	  showed	  that	  prenatal	  immune	  activation	  did	  not	  alter	  the	  total	  number	  of	  microglia	  cells	  in	  the	  dorsal	  CA	  and	  DG,	  neither	  in	   pubescence	   nor	   in	   adulthood	   (Fig.	   4A,B).	   There	   were	   also	   no	   group	   differences	   with	  regards	  to	  Iba1-­‐positive	  microglia	   in	  the	  ventral	  CA	  and	  DG	  subregions	  (Suppl.	   Fig.	   S3A).	  The	   number	   of	   Iba1-­‐positive	  microglia	   was	   generally	   lower	   in	   the	   dorsal	   CA	   of	   adult	   as	  compared	  to	  pubescent	  offspring,	  leading	  to	  a	  significant	  main	  effect	  of	  age	  [F(1,28)	  =	  6.06,	  
p	   <	   0.05].	   This	   age-­‐dependent	  decrease,	   however,	   similarly	   emerged	   in	  poly(I:C)-­‐exposed	  and	  control	  offspring	  (Fig.	  4A,B;	  Suppl.	  Fig.	  S3A).	  	  	   There	  were	  also	  no	  signs	  of	  altered	  microglia	  activation	  in	  poly(I:C)-­‐exposed	  relative	  to	  control	   offspring.	   We	   found	   no	   group	   differences	   with	   respect	   to	   cell	   soma	   area	   and	  primary	  or	  secondary	  branches	  of	  Iba1-­‐positive	  cells	  in	  the	  CA	  (Fig.	  4C)	  or	  DG	  subregions	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(Suppl.	  Fig.	  S4),	  suggesting	  that	  microglia	  morphology	  was	  not	  changed	  between	  poly(I:C)-­‐exposed	   relative	   to	   control	   offspring.	   Furthermore,	   the	   number	   of	   microglia	   expressing	  CD68,	  which	   is	   typically	   increased	   in	   the	   lysosome	  of	   activated	   (phagocytic)	   cells	   (Colton	  and	   Wilcock,	   2010),	   was	   not	   changed	   in	   the	   dorsal	   CA	   and	   DG	   subregions	   of	   poly(I:C)-­‐treated	  offspring	  relative	  to	  controls	  (Fig.	  4D,E).	  There	  were	  also	  no	  group	  differences	  with	  regards	   to	   CD68-­‐positive	   cells	   in	   the	   ventral	   CA	   and	   DG	   subregions	   (Suppl.	   Fig.	   S3B).	  Consistent	  with	  the	  age-­‐dependent	  decrease	  of	  Iba1-­‐positive	  cells	  (Fig.	  4A),	  the	  number	  of	  CD68-­‐positive	  microglia	  was	  generally	  lower	  in	  the	  dorsal	  CA	  and	  DG	  of	  adult	  as	  compared	  to	  pubescent	  offspring	  (Fig.	   4D),	   leading	   to	  a	  significant	  main	  effect	  of	  age	   [CA:	  F(1,28)	  =	  4.78,	  p	  <	  0.05;	  DG:	  F(1,28)	  =	  6.35,	  p	  <	  0.05].	  Similar	  findings	  were	  obtained	  for	  the	  ventral	  CA	  and	  DG	  subregions	  (Suppl.	  Fig.	  S3B).	  	   We	  further	  examined	  whether	  possible	  microglia	  alterations	  might	  exist	  in	  offspring	  of	  poly(I:C)-­‐mothers	  at	  an	  earlier	  maturational	  stage,	  namely	  at	  juvenile	  age	  (PND	  21).	  These	  additional	   analyses,	   however,	   similarly	   revealed	   no	   significant	   group	   differences	   with	  regards	   to	   Iba1-­‐or	  CD68-­‐positive	  microglia	  cells	   in	   the	   juvenile	  hippocampus	  (Suppl.	   Fig.	  
S5).	  Hence,	  we	  found	  no	  evidence	  for	  microgliosis	  or	  altered	  microglia	  activation	  in	  juvenile	  offspring	  exposed	  to	  prenatal	  viral-­‐like	  immune	  activation.	  	   Consistent	   with	   previous	   studies	   (Nyffeler	   et	   al.,	   2006),	   poly(I:C)-­‐induced	   prenatal	  immune	  activation	  did	  also	  not	  alter	  the	  numbers	  of	  GFAP-­‐positive	  in	  the	  hippocampus	  at	  pubescent	  or	  adult	  ages	  (Fig.	  4F,G).	  In	  the	  dorsal	  CA	  region,	  there	  was	  a	  general	  decrease	  in	  the	  number	  of	  astrocytes	  in	  adult	  relative	  to	  pubescent	  animals	  [main	  effect	  of	  age:	  F(1,28)	  =	   7.50,	   p	   <	   0.05],	   whereas	   an	   opposite	   age-­‐dependent	   effect	   emerged	   in	   the	   dorsal	   DG	  region	  [main	  effect	  of	  age:	  F(1,28)	  =	  9.16,	  p	  <	  0.01].	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3.5.	  Prenatal	  immune	  activation	  increases	  hippocampal	  IL-­‐1β	  levels	  in	  adulthood	  As	   depicted	   in	   Fig.	   5A,	   we	   found	   that	   prenatal	   immune	   activation	   selectively	   increased	  hippocampal	  IL-­‐1β	  levels	  in	  adult	  but	  not	  pubescent	  offspring.	  ANOVA	  of	  hippocampal	  IL-­‐1β	  revealed	  a	  significant	  interaction	  between	  prenatal	  treatment	  and	  age	  [F(1,32)	  =	  4.90,	  p	  <	  0.05],	   and	   subsequent	   post-­‐hoc	   analyses	   confirmed	   the	   significant	   group	   difference	   in	  hippocampal	  IL-­‐1β	  levels	  at	  adult	  age	  (p<	  0.05).	  Prenatal	  immune	  activation	  did	  not	  affect	  the	  hippocampal	   levels	   of	   the	  other	   cytokines	  of	   interest	   (IL-­‐4,	   IL-­‐6	   and	  TNF-­‐α;	  Fig.	   5A).	  There	  was	   only	   a	   general	   age-­‐dependent	   effect	   for	   the	   hippocampal	   levels	   of	   IL-­‐4	   [main	  effect	  of	  age:	  F(1,32)	  =	  5.63,	  p	  <	  0.05]	  and	   	  TNF-­‐α	   [main	  effect	  of	  age:	  F(1,32)	  =	  4.82,	  p	  <	  0.05],	  with	  lower	  levels	  measured	  in	  adult	  as	  compared	  to	  pubescent	  offspring	  (Fig.	  5A).	  	   No	  group	  differences	  in	  plasma	  levels	  of	  IL-­‐1β,	  IL-­‐4,	  IL-­‐6	  or	  TNF-­‐α	  were	  detected	  (Fig.	  
5B),	   indicating	   that	   prenatal	   immune	   activation	   did	   not	   induce	   systemic	   inflammation	   at	  pubescent	  or	  adult	  ages.	  Plasma	  levels	  of	  IL-­‐1β	  and	  TNF-­‐α	  generally	  decreased	  as	  a	  function	  of	  age	  (Fig.	  5B),	  leading	  to	  significant	  main	  effects	  of	  age	  [IL-­‐1β:	  F(1,32)	  =	  17.29,	  p	  <	  0.001;	  TNF-­‐α:	  F(1,32)	  =	  6.72,	  p	  <	  0.05].	  No	  other	  main	  effects	  or	  interactions	  attained	  significance.	  	  
	  
	  
4.	  Discussion	  	  The	  present	  study	  demonstrates	  that	  viral-­‐like	  prenatal	  immune	  activation	  in	  mice	  impairs	  the	   expression	   of	   major	   pre-­‐	   and	   post-­‐synaptic	   synaptic	   proteins	   in	   the	   hippocampal	  formation.	  Consistent	  with	  other	  findings	  (Oh-­‐Nishi	  et	  al.,	  2010),	  we	  have	  previously	  shown	  that	   the	   same	   prenatal	   manipulation	   does	   not	   lead	   to	   neuronal	   loss	   in	   this	   brain	   area	  (Nyffeler	  et	  al.,	  2006).	  It	  thus	  follows	  that	  hippocampal	  synaptic	  deficits	  emerging	  following	  prenatal	  viral-­‐like	  immune	  activation	  are	  not	  secondary	  to	  neuronal	  loss.	  Interestingly,	  the	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nature	  of	  synaptic	  deficits	   induced	  by	  this	  prenatal	   insult	  was	  markedly	  influenced	  by	  the	  maturational	   stage	   of	   the	   offspring.	   Clear	   deficits	   in	   the	   expression	   of	   the	   presynaptic	  proteins	  synaptophysin	  and	  bassoon	  were	  evident	  only	  in	  adult	  but	  not	  pubescent	  offspring	  of	   immune-­‐challenged	  mothers.	   In	  contrary,	  prenatal	   immune	  activation	   led	  to	  a	  decrease	  in	  the	  expression	  of	  the	  major	  postsynaptic	  protein	  PSD95	  regardless	  of	  the	  offspring’s	  age.	  In	  addition,	   it	   impaired	  hippocampal	  SynGap	  expression	   specifically	   in	  pubescent	  but	  not	  adult	  offspring.	  It	  thus	  seems	  that	  prenatal	  viral-­‐like	  immune	  activation	  can	  led	  to	  an	  early	  pubescent	  onset	  of	  postsynaptic	  hippocampal	  deficits,	  whereas	  presynaptic	  abnormalities	  are	   only	   manifested	   once	   the	   offspring	   reach	   adulthood.	   Our	   study	   does	   not	   provide	  insights	   into	   the	   developmental	   processes	   underlying	   this	   differential	   temporal	   onset.	  Hence,	   it	   remains	   elusive	   whether	   they	   may	   be	   somehow	   interrelated,	   or	   alternatively,	  whether	   distinct	   developmental	   processes	   may	   be	   involved.	   In	   support	   of	   the	   former	  possibility,	  however,	   it	  has	  been	  shown	  that	  postsynaptic	  proteins	  can	  induce	  presynaptic	  assembly	   and	   drive	   the	   formation	   of	   new	   presynaptic	   contacts	   (Biederer	   et	   al.,	   2002;	  Scheiffele	  et	  al.,	  2000).	  Furthermore,	  the	  postsynaptic	  scaffolding	  protein	  PSD95,	  along	  with	  its	   interaction	   partners,	   can	   modulate	   the	   release	   probability	   of	   presynaptic	   transmitter	  vesicles	   in	   a	   retrograde	   manner	   (Futai	   et	   al.,	   2007).	   The	   early	   onset	   of	   postsynaptic	  deficiencies	   identified	   here	   is	   consistent	   with	   previous	   findings	   showing	   that	   prenatal	  immune	  activation	   induces	  early	  developmental	  changes	   in	   the	  expression	  of	  N-­‐methyl-­‐D-­‐aspartate	  (NMDA)	  receptor	  subunits	  (Khalil	  et	  al.,	  2013),	  which	  co-­‐localize	  with	  several	  PSD	  proteins	  such	  as	  PSD95	  (Sheng,	  2001).	  Therefore,	  it	  could	  be	  speculated	  that	  the	  presence	  of	   early	   (pubescent)	   postsynaptic	   deficits	   may	   facilitate	   or	   even	   drive	   the	   subsequent	  development	  of	  presynaptic	  deficits,	  which	  in	  turn	  would	  appear	  only	  with	  a	  certain	  delay	  in	  adulthood.	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Interestingly,	  the	  delayed	  emergence	  of	  presynaptic	  hippocampal	  deficits	  coincided	  with	   the	   adult	   onset	   of	   prenatal	   infection-­‐induced	   PPI	   deficits.	   The	   adult	   emergence	   of	  poly(I:C)-­‐induced	   PPI	   deficit	   is	   consistent	   with	   numerous	   previous	   studies	   in	   mice	   (e.g.,	  Lipina	  et	  al.,	  2013;	  Pacheco-­‐López	  et	  al.,	  2013;	  Vuillermot	  et	  al.,	  2010)	  and	  rats	  (Hadar	  et	  al.,	  2015;	   but	   see	   also	   Wolff	   and	   Bilkey,	   2010).	   Since	   the	   hippocampal	   formation	   is	   one	   of	  several	   neuronal	   substrates	   modulating	   sensorimotor	   gating	   (Bast	   and	   Feldon,	   2003),	  deficient	   hippocampal	   expression	   of	   presynaptic	   proteins	   may	   readily	   contribute	   to	   the	  attenuation	  of	  PPI	   in	   immune-­‐challenged	  offspring.	  Even	  though	  this	  hypothesis	  warrants	  further	   examination,	   it	   would	   be	   consistent	   with	   other	   environmental	   stress	   models	  showing	   an	   association	   between	   reduced	   hippocampal	   synaptophysin	   expression	   and	  emergence	  of	  PPI	  deficits	   (Varty	   et	   al.,	   1999).	  Besides	  post-­‐pubertal	   synaptic	  deficits,	   the	  delayed	   onset	   of	   prenatal	   poly(I:C)-­‐induced	   deficits	   in	   PPI	   may	   also	   involve	   altered	  functional	  maturation	  of	  the	  subcortical	  dopamine	  system	  (Hadar	  et	  al.,	  2015;	  Vuillermot	  et	  al.,	  2010),	  brain	  volumetric	  changes	  throughout	  adolescence	  (Piontkewitz	  et	  al.,	  2011),	  and	  altered	  maturation	  of	  prefrontal	  GABAergic	  systems	  (Richetto	  et	  al.,	  2014).	  It	  should	  also	  be	  noted	  that	  prenatal	  poly(I:C)-­‐induced	  immune	  activation	  can	  lead	  to	  various	  behavioral	  and	  neuronal	  abnormalities	  with	  early	  juvenile	  or	  adolescent	  onsets,	  including	  hypersensitivity	  to	   dopamine-­‐stimulating	   psychotomimetic	   drugs	   (Meyer	   et	   al.,	   2008,;	   Vuillermot	   et	   al.,	  2010),	  cognitive	  deficits	  (Richetto	  et	  al.,	  2013),	  impairments	  in	  	  social	  interaction	  (Aavani	  et	  al.,	  2015),	   and	  deficits	   in	  hippocampal	  neurogenesis	   (Meyer	  et	  al.,	  2006).	  Hence,	  whereas	  the	   present	   findings	   may	   be	   more	   important	   for	   neuropsychiatric	   disorders	   with	   adult	  onsets,	   prenatal	   immune	   activation	   models	   are	   generally	   also	   relevant	   for	  neurodevelopmental	   disorders	   that	   are	   characterized	   by	   overt	   symptomatology	   in	  childhood	  or	  early	  adolescence.	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Besides	   their	  potential	   involvement	   in	  PPI,	   the	  synaptic	  deficits	   identified	  here	  are	  likely	   to	   contribute	   to	   other	   functional	   abnormalities	   typically	   associated	   with	   prenatal	  viral-­‐like	  immune	  activation.	  In	  particular,	  the	  disruption	  of	  hippocampal	  synaptic	  integrity	  may	  change	   the	  electrophysiological	  properties	  of	  hippocampal	   cells,	   thereby	  altering	   the	  firing	   activity	   of	   hippocampal	   neurons.	   Such	   abnormalities	   have	   indeed	   been	   noted	   by	  numerous	  previous	  investigations	  using	  prenatal	  poly(I:C)	  models	  in	  rodents	  (Dickerson	  et	  al.,	  2010,	  2014;	  Savanthrapadian	  et	  al.,	  2013;	  Wolff	  and	  Bilkey,	  2015;	  Zhang	  and	  van	  Praag,	  2015).	  Furthermore,	  the	  synaptic	  deficits	  may	  also	  contribute	  to	  the	  cognitive	  impairments	  that	   have	   frequently	   been	   observed	   following	   prenatal	   immune	   activation	   (reviewed	   in	  Boksa,	  2010;	  Harvey	  and	  Boksa,	  2012;	  Meyer	  and	  Feldon,	  2010;	  Reisinger	  et	  al.,	  2015).	  	  Based	  on	  the	  growing	  evidence	  suggesting	  an	  important	  role	  of	  microglia	  in	  forming	  and	   maintaining	   synaptic	   integrity	   (Bilimoria	   and	   Stevens,	   2015;	   Kreisel	   et	   al.,	   2014;	  Paolicelli	  et	  al.,	  2011;	  Schafer	  et	  al.,	  2012;	  Schafer	  and	  Stevens,	  2013),	  we	  hypothesized	  that	  the	   prenatal	   infection-­‐induced	   synaptic	   abnormalities	   would	   be	   associated	   with	   altered	  densities	   and/or	   activation	  patterns	  of	  microglia.	   Contrary	   to	   this	  hypothesis,	  we	  did	  not	  find	   any	   evidence	   for	   overt	   microglia	   abnormalities	   in	   offspring	   exposed	   to	   poly(I:C)-­‐induced	   prenatal	   immune	   activation.	   In	   fact,	   our	   data	   highlight	   that	   a	   prenatal	   poly(I:C)	  challenge,	   which	   is	   effective	   in	   causing	   marked	   deficits	   in	   hippocampal	   synaptic	   protein	  expression	   and	   behavioral	   abnormalities,	   does	   not	   necessarily	   lead	   to	   increased	   Iba1-­‐postive	   microglia	   (or	   GFAP-­‐positive	   astrocyte)	   density	   in	   the	   offspring’s	   hippocampal	  formation.	  We	  were	  also	  unable	  to	  detect	  signs	  of	  altered	  microglia	  activation	  in	  poly(I:C)-­‐exposed	  offspring,	  as	  evaluated	  by	  microglia	  morphology	  and	  CD68	  immunoreactivity.	  We	  acknowledge	   that	   our	   study	   was	   not	   designed	   to	   detect	   possible	   changes	   in	   microglia	  functions	  that	  could	  occur	  at	  early	  fetal	  or	  neonatal	  developmental	  windows	  (Arsenault	  et	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al.,	   2014;	   Pratt	   et	   al.,	   2013).	   Therefore,	   our	   study	   does	   not	   negate	   a	   possible	   role	   of	  microglia	  in	  mediating	  early	  neurodevelopmental	  effects	  of	  prenatal	  immune	  activation.	  	  At	  the	   same	   time,	   however,	   the	   design	   of	   our	   study	   readily	   allowed	   us	   to	   identify	   potential	  microglia	  abnormalities	   from	  the	  pubescent	   (PND	  40)	   to	   the	  adult	   (PND	  90)	  stage	  and	   to	  establish	  a	  putative	  association	  with	  pre-­‐	  and	  postsynaptic	  hippocampal	  deficits.	  Since	  our	  study	   failed	   to	  establish	   such	  an	  association,	  we	   feel	   it	   is	   reasonable	   to	   conclude	   that	   the	  adult	  onset	  of	  hippocampal	  synaptic	  deficits	  was	  not	  primarily	  the	  result	  of	  altered	  synaptic	  pruning	   by	   microglia.	   Based	   on	   our	   additional	   evaluation	   of	   possible	   microglia	  abnormalities	   at	   an	   earlier	   juvenile	   (PND	   21)	   stage,	   we	   believe	   that	   altered	   synaptic	  pruning	  by	  microglia	  similarly	  plays	  only	  a	  minor	  role	  in	  inducing	  the	  hippocampal	  synaptic	  deficits	  in	  the	  pubescent	  offspring	  of	  infected	  mothers.	  	  	  Hence,	   even	   though	   abnormalities	   in	   microglia	   functions	   can	   occur	   following	  prenatal	   immune	   challenge	   (Borrell	   et	   al.,	   2002;	   Juckel	   et	   al.,	   2011;	  Van	  den	  Eynde	  et	   al.,	  2014;	  Zhu	  et	   al.,	   2014),	   our	   findings	   suggest	   that	   such	   changes	  are	  not	   a	  prerequisite	   for	  synaptic	   deficits	   to	   occur,	   at	   least	   within	   the	   dorsal	   and	   ventral	   hippocampus.	   This	  interpretation	   is	   consistent	   with	   the	   findings	   derived	   from	   disease	   models	   of	   chronic	  neurodegeneration,	  suggesting	  that	  microglia	  do	  not	  play	  an	  active	  role	   in	  either	  synaptic	  stripping	   or	   synapse	   degeneration	   in	   the	   hippocampal	   formation	   (Perry	   and	   O'Connor,	  2010;	   Sisková	   et	   al.,	   2009).	   Instead,	   these	  models	   highlight	   that	   synaptic	   elimination	   and	  envelopment	  of	  degenerating	  terminals	  can	  be	  a	  neuron	  autonomous	  event.	  Furthermore,	  our	   interpretation	   is	   also	   in	   line	   with	   other	   studies	   using	   the	   prenatal	   poly(I:C)	  administration	  model	  showing	  that	  significant	  neuronal	  and	  behavioral	  abnormalities	  can	  occur	   in	   the	   absence	   of	   overt	  microglia	   abnormalities	   (Garay	   et	   al.,	   2013;	  Missault	   et	   al.,	  2914;	   Pineda	   et	   al.,	   2013;	   Willi	   et	   al.,	   2013).	   Additional	   investigations	   will	   therefore	   be	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needed	   to	   identify	   the	   cellular	   and	   molecular	   processes	   underlying	   the	   emergence	   of	  hippocampal	   synaptic	   deficits	   following	   prenatal	   immune	   challenge.	   On	   speculative	  grounds,	  one	  possible	  mechanism	  may	  be	  related	  to	  impairments	  in	  postnatal	  hippocampal	  neurogenesis,	   which	   have	   been	   repeatedly	   found	   in	   various	   models	   of	   prenatal	   immune	  challenge	  (Cardon	  et	  al.,	  2010;	  Cui	  et	  al.,	  2009;	  Meyer	  et	  al.,	  2006,	  2010;	  Piontkewitz	  et	  al.,	  2012b;	  Zhang	  and	  van	  Praag,	  2015).	  An	  alternative	  (but	  not	  mutually	  exclusive)	  mechanism	  may	  relate	  to	  epigenetic	  modifications	  impacting	  on	  the	  transcription	  of	  genes	  that	  encode	  for	  synaptic	  proteins.	  Even	  though	  this	  possibility	  warrants	  direct	  examination,	  epigenetic	  modifications	  at	  other	  gene	  loci	  have	  recently	  been	  identified	  in	  mouse	  models	  of	  prenatal	  immune	  activation	  (Basil	  et	  al.,	  2014;	  Connor	  et	  al.,	  2012;	  Hollins	  et	  al.,	  2014;	  Tang	  et	  al.,	  2013).	   Yet	   another	   possibility	   would	   be	   that	   the	   emergence	   of	   hippocampal	   synaptic	  deficits	  following	  prenatal	  immune	  activation	  might	  involve	  (developmental)	  changes	  in	  the	  kynurenine	  pathway.	  As	  discussed	  in	  detail	  elsewhere	  (Schwarcz	  et	  al.,	  2012),	  this	  pathway	  is	  strongly	  influenced	  by	  inflammatory	  processes,	  so	  that	  some	  effects	  of	  prenatal	  poly(I:C)-­‐induced	   immune	   activation	  might	   be	  mediated	  by	   transient	   and/or	   long-­‐term	   changes	   in	  the	  synthesis	  of	  kynurenine	  and	  its	  metabolites.	  Circumstantial	  support	  for	  this	  hypothesis	  derives	   from	  studies	   showing	   that	   inhibition	  of	   the	  kynurenine	  pathway	  during	  gestation	  can	  lead	  to	  changes	  in	  synaptic	  transmission,	  neuronal	  morphology	  and	  plasticity	  in	  the	  rat	  hippocampus	   (Forrest	   et	   al.,	   2013a,b;	   Khalil	   et	   al.,	   2014).	   Whatever	   precise	   mechanism	  involved,	   we	   believe	   that	   the	   deficits	   in	   hippocampal	   synaptic	   proteins	   emerging	   in	  pubescent	   and/or	   adult	   offspring	   of	   infected	   mothers	   may	   have	   an	   early	   developmental	  origin	  rather	  than	  being	  the	  result	  of	  abnormal	  microglia	  functions	  and	  associated	  changes	  in	  adolescent	  synaptic	  pruning.	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In	  fact,	  the	  age-­‐dependent	  increase	  in	  hippocampal	  synaptophysin	  expression,	  which	  was	   seen	   in	   both	   poly(I:C)-­‐exposed	   and	   control	   offspring,	   may	   even	   more	   generally	  question	  whether	   the	  mouse	  hippocampal	   formation	  undergoes	  marked	  synaptic	  pruning	  between	  pubescence	  and	  adulthood.	  Synaptophysin	  is	  one	  of	  the	  most	  widely	  used	  synaptic	  markers,	   which	   is	   typically	   taken	   to	   index	   synaptic	   integrity	   and	   presynaptic	   density	  (Elferink	   and	   Scheller,	   1995;	   Wiedenmann	   and	   Franke,	   1985).	   Synaptophysin	   is	   already	  expressed	  during	  early	  neuronal	  differentiation,	  where	   it	  appears	  to	  have	   important	  roles	  in	   synapse	   formation	   (Eastwood	  et	   al.,	   2006;	  Friedman	  et	   al.,	   2000;	  Zai	   et	   al.,	   2000).	  The	  present	   findings	   of	   an	   age-­‐dependent	   increase	   in	   hippocampal	   synaptophysin	   expression	  are	   consistent	   with	   previous	   studies	   that	   examined	   its	   basal	   expression	   from	   the	   early	  neonatal	  to	  the	  adolescent	  period	  (Eastwood	  et	  al.,	  2006).	  Similar	  to	  our	  results,	  Eastwood	  et	   al.	   (2006)	   did	   not	   find	   any	   evidence	   for	   an	   adolescence-­‐related	   decline	   in	   basal	  hippocampal	   synaptophysin	   expression,	   as	   it	   is	   seen,	   for	   example,	   in	   cortical	   brain	   areas	  (Glantz	  et	  al.,	  2007;	  but	  see	  also	  Webster	  et	  al.,	  2011).	  In	  as	  much	  as	  synaptophysin	  can	  be	  considered	   a	   presynaptic	  marker	   (Elferink	   and	   Scheller,	   1995;	  Wiedenmann	   and	   Franke,	  1985),	  our	  findings	  presented	  here,	  together	  with	  those	  reported	  by	  Eastwood	  et	  al.	  (2006),	  suggest	  that	  the	  overall	  presynaptic	  density	  in	  the	  hippocampus	  is	  not	  reduced	  but	  rather	  increased	  between	  pubescence	  and	  adulthood.	  At	   the	   same	   time	   however,	   we	   found	   that	   the	   hippocampal	   expression	   of	   the	  presynaptic	  protein	  bassoon	  generally	  decreased	  from	  pubescence	  to	  adulthood.	  This	  is	  in	  stark	  contrast	  to	  the	  expression	  pattern	  of	  synaptophysin,	  which	  generally	  increased	  from	  pubescent	   to	   adulthood.	   We	   admit	   that	   we	   have	   no	   parsimonious	   explanation	   for	   this	  differential	   pattern	   of	   temporal	   expression.	   On	   speculative	   grounds,	   however,	   this	  difference	   may	   be	   explained	   by	   the	   distinct	   role	   of	   these	   two	   presynaptic	   proteins	   in	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governing	   synaptic	   strength	   and	  neurotransmitter	   release.	   The	   vesicle-­‐associated	  protein	  synaptophysin	   is	   involved	   in	   the	   regulation	  of	   synaptic	   strength	   (Han	  and	  Stevens,	   2009;	  Schmitt	   et	   al.,	   2009),	   but	   it	   does	   not	   seem	   to	   be	   required	   for	   the	   actual	   release	   of	  neurotransmitters	   from	   presynaptic	   vesicles	   (McMahon	   et	   al.,	   1996).	   On	   the	   other	   hand,	  bassoon	   is	   a	   scaffold	   protein	   of	   the	   presynaptic	   active	   zone	   and	   critically	   determines	  presynaptic	   neurotransmitter	   release	   through	   various	   (but	   not	   mutually	   exclusive)	  mechanisms	  (Davydova	  et	  al.,	  2014;	  Matz	  et	  al.,	  2010;	  Mendoza	  Schulz	  et	  al.,	  2014;	  Schröder	  et	   al.,	   2013;),	   including	   reloading	   of	   presynaptic	   vesicles	   to	   release	   sites	   at	   excitatory	  synapses	   (Hallermann	   et	   al.,	   2010).	   Based	   on	   our	   data,	   it	   may	   be	   speculated	   that	  hippocampal	   synaptic	   strength	   generally	   increases	   from	   pubescence	   to	   adulthood	   (as	  indexed	  by	  the	  overall	  increase	  in	  synaptophysin	  expression	  in	  adult	  relative	  to	  pubescent	  animals),	  which	  is	  consistent	  with	  the	  maturation-­‐dependent	  increases	  in	  synaptic	  strength	  occurring	  in	  other	  brain	  areas	  (Kasanetz	  and	  Manzoni,	  2009).	  One	  limitation	  of	  our	  study	  is,	  however,	   that	   we	   cannot	   further	   define	   whether	   the	   age-­‐dependent	   changes	   in	  synaptophysin	   expression	   may	   reflect	   alterations	   in	   the	   number	   of	   presynaptic	   contacts	  and/or	  variations	  in	  the	  number	  of	  presynaptic	  vesicles	  per	  synapse.	  Moreover,	  it	  remains	  to	   be	   further	   explored	   whether	   the	   age-­‐dependent	   changes	   in	   hippocampal	   bassoon	  expression	   may	   reflect	   changes	   in	   neurotransmitter	   reloading	   and/or	   basal	  neurotransmitter	   release,	   and	  whether	   they	   are	   specific	   to	   a	   certain	  neuronal	   population	  (e.g.,	   excitatory	  pyramidal	   cells	  or	   inhibitory	   interneurons).	  Despite	   these	   limitations,	  our	  results	   tentatively	   suggest	   that	   prenatal	   immune	   activation	   impairs	   the	   maturation	   of	  presynaptic	  cellular	  processes	  that	  govern	  synaptic	  strength	  and	  neurotransmitter	  release.”	  Another	   intriguing	   finding	   of	   our	   study	   is	   that	   adult	   offspring	   of	   poly(I:C)-­‐exposed	  mothers	  display	  a	  significant	  increase	  in	  hippocampal	  IL-­‐1β	  expression	  even	  in	  the	  absence	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of	   overt	   changes	   in	  microglia	   density	   and/or	   activation	   status.	   Even	   though	   in	   line	   with	  other	  studies	  (Garay	  et	  al.,	  2013),	  this	  effect	  may	  seem	  paradoxical	  in	  view	  of	  the	  numerous	  observations	  suggesting	  that	  microglia,	  especially	  those	  acquiring	  a	  pro-­‐inflammatory	  (M1)	  phenotype,	   are	   the	  major	   source	   of	   IL-­‐1β	   (and	   other	   pro-­‐inflammatory	   cytokines)	   in	   the	  brain	  parenchyma	  (Hanisch,	  2002;	  Ransohoff	  and	  Perry,	  2009).	  Although	  this	  may	  hold	  true	  for	  various	  neuroinflammatory	  conditions,	   in	  which	  overt	  microgliosis	  and	   increased	  pro-­‐inflammatory	  microglia	  activity	  exist,	  it	  is	  unlikely	  to	  be	  the	  case	  in	  our	  model.	  We	  also	  did	  not	   find	   associations	   between	   IL-­‐1β	   expression	   in	   the	   hippocampus	   and	   plasma	   IL-­‐1β	  concentrations,	   or	   between	   hippocampal	   IL-­‐1β	   expression	   and	   astrocyte	   numbers.	   These	  findings	  indicate	  that	  neither	  systemic	  inflammation	  nor	  astrogliosis	  may	  be	  responsible	  for	  the	  increased	  hippocampal	  IL-­‐1β	  levels	  in	  adult	  offspring	  of	  poly(I:C)-­‐exposed	  mothers.	  In	  addition	   to	  microglia	   and	   astrocytes,	   however,	   neurons	   are	   known	   to	   express	   cytokines,	  including	  IL-­‐1β,	  as	  well	  (Acarin	  et	  al.,	  2000;	  Erta	  et	  al.,	  2012;	  Freidin	  et	  al.,	  1992;	  Liu	  et	  al.,	  2005).	   Neuronal	   sources	   of	   cytokines	   have	   received	   somewhat	   less	   attention,	   but	   still	  appear	  to	  be	  relevant	  under	  various	  pathological	  conditions	  such	  as	  stress	  exposure	  (Kwon	  et	  al.,	  2008)	  and	  gray	  matter	  damage	  (Acarin	  et	  al.,	  2000;	  Liu	  et	  al.,	  2005).	  Even	  though	  the	  underlying	   mechanisms	   and	   functional	   role	   of	   increased	   hippocampal	   IL-­‐1β	   expression	  remains	   to	   be	   examined	   in	   our	  model,	   our	   data	   clearly	   demonstrate	   that	   abnormal	   pro-­‐inflammatory	   cytokine	   expression	   in	   the	   brain	   can	   occur	   without	   concomitant	   microglia	  abnormalities.	   These	   findings	   may	   also	   have	   important	   implications	   for	   the	   current	  attempts	   to	   define	   “neuroinflammation”	   in	   neurodevelopmental	   disorders	   such	   as	  schizophrenia	   and	   autism,	   especially	   for	   those	   that	   rely	   on	   the	   examination	   of	  microglia	  only	  (Doorduin	  et	  al.,	  2009;	  Kenk	  et	  al.,	  2015;	  Morgan	  et	  al.,	  2010;	  Pasternak	  et	  al.,	  2015;	  Tetreault	  et	  al.,	  2012;	  van	  Berckel	  et	  al.,	  2008).	  
29	  
	  
In	  conclusion,	  our	  study	  shows	  that	  maternal	  poly(I:C)-­‐induced	  immune	  activation	  in	  mice	  causes	  age-­‐dependent	  hippocampal	  deficits	   in	  the	  offspring.	  Given	  the	  validity	  of	  the	  prenatal	   poly(I:C)	   administration	   model	   for	   neuropsychiatric	   disorders	   with	  neurodevelopmental	  components	   (Meyer	  and	  Feldon,	  2010;	  Meyer,	  2014;	  Reisinger	  et	  al.,	  2015),	   our	   findings	   suggest	   that	   prenatal	   infection	   and/or	   inflammation	  may	  be	   an	   early	  environmental	  risk	  factor	  for	  the	  development	  of	  synaptic	  abnormalities	  in	  these	  disorders.	  Another	   important	   implication	  of	  our	   findings	   is	   that	   the	  hippocampal	  synaptic	  deficits	   in	  offspring	   exposed	   to	   prenatal	   immune	   activation	  were	   not	   paralleled	   by	   overt	  microglial	  abnormalities,	  suggesting	  that	  the	  latter	  is	  not	  a	  prerequisite	  for	  the	  former.	  Interestingly,	  a	  recent	  study	  using	  the	  same	  poly(I:C)-­‐based	  immune	  activation	  model	  in	  mice	  showed	  that	  there	   were	   no	   significant	   differences	   in	   fetal	   microglial	   cell	   density	   or	   activation	   levels	  between	  offspring	  of	  immune-­‐stimulated	  and	  control	  mothers	  (Smolders	  et	  al.,	  2015).	  Our	  interpretations	   are	   consistent	   with	   these	   findings	   and	   generally	   question	   a	   major	  involvement	   of	   microglia-­‐driven	   processes	   in	   precipitating	   short-­‐	   and	   long-­‐term	  (hippocampal)	   abnormalities	   following	   prenatal	   immune	   activation.	   Future	   attempts	   to	  identify	  the	  mechanisms	  underlying	  these	  hippocampal	  deficits	  should	  thus	  go	  beyond	  the	  possible	  role	  of	  altered	  microglia	  functions.	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Figure	  1.	  Effects	  of	  prenatal	  immune	  activation	  on	  prepulse	  inhibition	  of	  the	  acoustic	  startle	  reflex.	  
(A)	   The	   line	   plot	   shows	   percent	   prepulse	   inhibition	   (%PPI)	   as	   a	   function	   of	   the	   3	   distinct	   pulse	  levels	  (P-­‐100,	  P-­‐110	  and	  P-­‐120,	  which	  correspond	  to	  100,	  110	  and	  120	  dBA)	  and	  prepulse	  levels	  (+6,	  +12	   and	   +18	   dBA	   above	   background	   of	   65	   dBA)	   for	   pubescent	   and	   adult	   offspring	   of	   poly(I:C)-­‐exposed	   (POL)	   and	   control	   (CON)	   mothers,	   and	   the	   bar	   plot	   depicts	   the	   mean	   %PPI	   across	   all	  prepulse	  and	  pulse	  stimuli	  used.	  §p	  <	  0.001,	  reflecting	  the	  significant	  difference	  between	  pubescent	  and	  adult	  offspring	  based	  on	  ANOVA;	   *p	  <	  0.05,	   reflecting	   the	  significant	  difference	  between	  adult	  CON	  and	  adult	  POL	  offspring	  based	  on	  Fisher’s	  LSD	  post-­‐hoc	   test.	  (B)	  The	   line	  plot	   illustrates	   the	  startle	   reactivity	   (in	   arbitrary	  units,	  AU)	   to	  pulse-­‐alone	   trials	   for	   the	  3	  different	  pulse	   levels.	   §p	   <	  0.05,	  reflecting	  the	  significant	  difference	  between	  pubescent	  and	  adult	  offspring	  based	  on	  ANOVA.	  

















Figure	  4.	  Effects	  of	  prenatal	  immune	  activation	  on	  microglia	  and	  astrocyte	  density	  and	  morphology.	  	  
(A)	   Stereological	   estimates	   of	   Iba1-­‐positive	  microglia	   in	   the	   dorsal	   cornu	   amonis	   (CA;	   CA1–CA3)	  and	   dentate	   gyrus	   (DG)	   of	   pubescent	   and	   adult	   offspring	   born	   to	   poly(I:C)-­‐exposed	   (POL)	   and	  control	  (CON)	  mothers.	  §p	  <	  0.05,	  reflecting	  the	  significant	  difference	  between	  pubescent	  and	  adult	  offspring	  based	  on	  ANOVA.	  (B)	  The	  photomicrograph	  shows	  a	  representative	  hippocampal	  section	  stained	  with	  anti-­‐Iba1	  antibody,	  and	  the	  inlet	  depicts	  Iba1-­‐positive	  microglia	  at	  high	  magnification.	  





Figure	  5.	  Effects	  of	  prenatal	  immune	  activation	  on	  cytokine	  levels	  in	  the	  hippocampus	  and	  plasma.	  	  








Supplementary	  Figure	  S1.	  Relative	  optical	  density	  (in	  arbitrary	  units,	  AU)	  of	  synaptophysin	  in	  the	  ventral	  cornu	  amonis	  (CA;	  CA1–CA3)	  and	  dentate	  gyrus	  (DG)	  of	  pubescent	  and	  adult	  offspring	  born	  to	   poly(I:C)-­‐exposed	   (POL)	   and	   control	   (CON)	   mothers.	   §p	   <	   0.001,	   reflecting	   the	   significant	  difference	   between	   pubescent	   and	   adult	   offspring	   based	   on	   ANOVA	   [CA:	   F(1,28)	   =	   36.43;	   DG:	  
F(1,28)	  =	  39.01];	   *p	  <	  0.05,	   reflecting	   the	  significant	  difference	  between	  adult	  CON	  and	  adult	  POL	  offspring	   based	   on	   Fisher’s	   LSD	   post-­‐hoc	   test	   following	   the	   presence	   of	   a	   significant	   interaction	  between	  prenatal	  treatment	  and	  age	  [CA:	  F(1,28)	  =	  5.26,	  p	  <	  0.05;	  DG:	  F(1,28)	  =	  5.83,	  p	  <	  0.05].	  N	  =	  8	  in	  each	  group;	  all	  values	  are	  means	  ±	  s.e.m.	  	  	  	  
	  	  
Supplementary	  Figure	  S2.	  Relative	  optical	  density	  (in	  arbitrary	  units,	  AU)	  of	  PSD95	  in	  the	  ventral	  cornu	   amonis	   (CA;	   CA1–CA3)	   and	   dentate	   gyrus	   (DG)	   of	   pubescent	   and	   adult	   offspring	   born	   to	  poly(I:C)-­‐exposed	  (POL)	  and	  control	  (CON)	  mothers.	  +p	  <	  0.001,	  reflecting	  the	  significant	  difference	  between	  CON	  and	  POL	  offspring	  associated	  with	  the	  main	  effect	  of	  prenatal	  treatment	  [CA:	  F(1,28)	  =	  28.71;	   DG:	   F(1,28)	   =	   20.36]	   revealed	   by	   ANOVA;	   §p	   <	   0.001,	   reflecting	   the	   significant	   difference	  between	  pubescent	   and	  adult	   offspring	  based	  on	   the	  main	   effect	   of	   age	   [CA:	  F(1,28)	  =	  26.13;	  DG:	  





Supplementary	   Figure	   S3.	   (A)	   Stereological	   estimates	   of	   Iba1-­‐positive	   microglia	   in	   the	   ventral	  cornu	   amonis	   (CA;	   CA1–CA3)	   and	   dentate	   gyrus	   (DG)	   of	   pubescent	   and	   adult	   offspring	   born	   to	  poly(I:C)-­‐exposed	   (POL)	   and	   control	   (CON)	   mothers.	   #p	   <	   0.05	   and	   §p	   <	   0.01,	   reflecting	   the	  significant	  difference	  between	  pubescent	  and	  adult	  offspring	  based	  on	   the	  main	  effect	  of	   age	   [CA:	  




Supplementary	   Figure	   S4.	   (A)	   Cell	   soma	   area,	   number	   of	   primary	   processes,	   and	   number	   of	  secondary	   processes	   of	   Iba1-­‐positive	  microglia	   in	   the	   dentate	   gyrus	   (DG)	   of	   pubescent	   and	   adult	  CON	  and	  POL	  offspring.	  §p	  <	  0.01,	  reflecting	  the	  significant	  difference	  between	  pubescent	  and	  adult	  offspring	   based	   on	   the	   main	   effect	   of	   age	   [cell	   soma	   area:	   F(1,28)	   =	   8.98,	   p	   <	   0.01;	   number	   of	  secondary	  processes:	  F(1,28)	  =	  10.36,	  p	  <	  0.01]	  revealed	  by	  ANOVA.	  N	  =	  8	  in	  each	  group;	  all	  values	  are	  means	  ±	  s.e.m.	  	  	   	  
	  	  
Supplementary	   Figure	   S5.	   Microglia	   parameters	   in	   juvenile	   offspring	   of	   prenatally	   immune-­‐challenged	   and	   control	   mothers.	   Pregnant	   C57BL6/N	   female	   mice	   were	   treated	   with	   the	   viral	  mimetic	  poly(I:C)	  (5mg/kg,	  i.v.)	  or	  control	  vehicle	  solution	  (sterile	  pyrogen-­‐free	  0.9%	  NaCl),	  and	  the	  resulting	  offspring	  were	  killed	  shortly	  after	  weaning	  on	  postnatal	  day	  21	  for	  immunohistochemical	  analyses	  of	  microglia	  parameters	  as	  fully	  described	  in	  the	  main	  text.	  (A)	  Stereological	  estimates	  of	  Iba1-­‐positive	   microglia	   in	   the	   hippocampal	   formation	   (including	   CA1–CA3	   and	   dentate	   gyrus	  region)	   of	   juvenile	   offspring	   born	   to	   poly(I:C)-­‐exposed	   (POL)	   and	   control	   (CON)	   mothers.	   (B)	  Relative	   optical	   density	   (in	   arbitrary	   units,	   AU)	   of	   CD68	   immunoreactivity	   in	   the	   hippocampal	  formation	   (including	   CA1–CA3	   and	   dentate	   gyrus	   region)	   of	   juvenile	   POL	   and	   CON	   offspring.	  
N(CON)	  =	  9	  and	  N(POL)	  =	  10;	  the	  offspring	  stemmed	  from	  12	  independent	  litters	  (6	  CON	  and	  6	  POL	  litters).	  All	  values	  are	  means	  ±	  s.e.m.	  
